Rowsley says sale price of TMC Life Sciences warrants set at $34.8 mil

SINGAPORE (Mar 19): Rowsley says the cash consideration for the warrants of TMC Life Sciences (TMCLS) is set at RM103.75 million ($34.8 million).

This is derived from the volume weighted average price of TMCLS warrants traded on Bursa Securities for the one-month period to March 19 of MYR 0.1737 per warrant, multiplied by an aggregate of some 597.3 million TMCLS warrants.

As announced last Dec, Rowsley is acquiring the healthcare businesses of Thomson Medical from controlling shareholder Peter Lim for $1.6 billion.

---

Related Stories

• Thomson Medical prices $160 mil of notes due 2029 at 4.65%
• 'A transitional year' for Thomson Medical Group, as Maybank lowers target price to 6 cents
• Thomson Medical Group launches and prices $45 mil worth of notes

---